Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002087:Butyrates / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood*; D003864:Depression, Chemical; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D008055:Lipids / Q000097:blood; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010743:Phospholipids / Q000097:blood*; D051381:Rats; D012146:Rest
D000924:Anticholesteremic Agents; D002087:Butyrates; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010743:Phospholipids; D000324:Adrenocorticotropic Hormone; D002784:Cholesterol; D009638:Norepinephrine; D004837:Epinephrine